Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: A review - Abstract

Prostate cancer is diverse in clinical presentation, histopathological tumor growth patterns, and survival.

Therefore, individual assessment of a tumor's aggressive potential is crucial for clinical decision-making in men with prostate cancer. To date a large number of prognostic markers for prostate cancer have been described, most of them based on radical prostatectomy specimens. However, in order to affect clinical decision-making, validation of respective markers in pretreatment diagnostic needle-biopsies is essential. Here, we discuss established and promising histopathological and molecular parameters in diagnostic needle-biopsies.

Written by:
Hoogland AM, Kweldam CF, van Leenders GJ.   Are you the author?
Department of Pathology, Josephine Nefkens Institute, Room Be-206, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

Reference: Biomed Res Int. 2014;2014:341324.
doi: 10.1155/2014/341324

 
PubMed Abstract
PMID: 25243131

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe